MedPath

COSMETIQUE ACTIVE INTERNATIONAL

🇫🇷France
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.loreal.fr

Toleriane Ultra Reno in Allergic Subjects With Skin Intolerance to Their Usual Cosmetic

Completed
Conditions
Allergy
Interventions
Other: Use of Toleriane Ultra to relieve face allergic skin
First Posted Date
2022-08-04
Last Posted Date
2022-08-04
Lead Sponsor
Cosmetique Active International
Target Recruit Count
109
Registration Number
NCT05487937
Locations
🇵🇱

Dermscan Poland Sp. z o. o., Gdańsk, Poland

Management of Side-Effects of Anti-Acne Treatment by a Cosmetic Routine

Completed
Conditions
Acne
First Posted Date
2022-08-04
Last Posted Date
2022-08-04
Lead Sponsor
Cosmetique Active International
Target Recruit Count
44
Registration Number
NCT05486910
Locations
🇵🇱

Studio Dermatologia i Kosmetyka, Malbork, Poland

Normaderm Phytosolution Global Observational Study

Completed
Conditions
Acne, Adult
First Posted Date
2022-08-02
Last Posted Date
2022-08-02
Lead Sponsor
Cosmetique Active International
Target Recruit Count
2827
Registration Number
NCT05483205
Locations
🇧🇬

EuroDerma Clinic, Sofia, Bulgaria

🇷🇺

State Dermatological Clinic #10, Saint Petersburg, Russian Federation

🇸🇰

Amdv s.r.o. kozna amb, Prešov, Slovakia

and more 8 locations

Satisfaction Survey - Cicaplast Mains

Completed
Conditions
Hand Dermatoses
Hand Eczema
First Posted Date
2022-07-25
Last Posted Date
2022-07-25
Lead Sponsor
Cosmetique Active International
Target Recruit Count
380
Registration Number
NCT05471934
Locations
🇸🇮

Dermatology practices, Ljubljana, Slovenia

Efficacy and Tolerance of Formula 609613 37 in Acneic Patients

Not Applicable
Completed
Conditions
Acne
Interventions
Other: moisturizing cream and 5% benzoyl peroxide gel
Other: anti-acne face cream and 5% benzoyl peroxide gel
First Posted Date
2022-07-22
Last Posted Date
2022-07-22
Lead Sponsor
Cosmetique Active International
Target Recruit Count
100
Registration Number
NCT05469880

Effectiveness and Tolerance of Effaclar Serum in Women With Mandibular Acne

Not Applicable
Completed
Conditions
Acne Vulgaris
Interventions
Other: Effaclar serum
First Posted Date
2022-07-14
Last Posted Date
2022-07-14
Lead Sponsor
Cosmetique Active International
Target Recruit Count
30
Registration Number
NCT05457621
Locations
🇫🇷

Centre de Pharmacologie Clinique Appliquée à la Dermatologie (CPCAD), Nice, France

Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis

Not Applicable
Terminated
Conditions
Atopic Dermatitis
Eczema
Asthma
Food Allergies
Allergic Rhinitis
Interventions
Drug: Lipikar Balm AP
First Posted Date
2012-04-16
Last Posted Date
2016-04-21
Lead Sponsor
Cosmetique Active International
Target Recruit Count
2
Registration Number
NCT01577628
Locations
🇨🇦

Windsor Clinical Research, Windsor, Ontario, Canada

🇺🇸

Hamzavi Dermatology/Dermatology Specialists of Canton, Canton, Michigan, United States

🇺🇸

Hamzavi Dermatology, Fort Gratiot, Michigan, United States

and more 1 locations

Comparison of Redermic, Rejuva-A and Combination of Both Redermic and Rejuva-A in Subjects With Signs of Aging

Not Applicable
Completed
Conditions
Skin Aging
Interventions
First Posted Date
2009-09-10
Last Posted Date
2011-09-20
Lead Sponsor
Cosmetique Active International
Target Recruit Count
120
Registration Number
NCT00974480
Locations
🇨🇦

Innovaderm Research Inc, Montreal, Quebec, Canada

Tolerance and Efficacy of Formulation 609580 20 Versus Formulation 609209 in Children With Atopic Dermatitis

Not Applicable
Terminated
Conditions
Atopic Dermatitis
Interventions
Other: Formulation 609580 20
Other: Formulation 609209 (Lipikar Baume)
First Posted Date
2009-07-02
Last Posted Date
2011-09-20
Lead Sponsor
Cosmetique Active International
Target Recruit Count
73
Registration Number
NCT00931411
Locations
🇨🇦

Centre de recherche dermatologique du Québec Métropolitain, Quebec, Canada

🇨🇦

The Guenther Dermatology Research Center, London, Ontario, Canada

🇨🇦

Innovaderm Research Inc, Montreal, Quebec, Canada

and more 1 locations

Efficacy and Tolerance of a Derivative of Salicylic Acid and 5% Benzoyl Peroxide in Facial Acne Vulgaris

Not Applicable
Completed
Conditions
Acne Vulgaris
Interventions
Drug: Lipo Hydroxy Acid
Drug: 5% benzoyl peroxide gel
First Posted Date
2008-02-27
Last Posted Date
2011-09-20
Lead Sponsor
Cosmetique Active International
Target Recruit Count
80
Registration Number
NCT00624676
Locations
🇨🇦

Innovaderm Research, Montreal, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath